Product Code:165067
Published Date: Sep 01,2021
Pages: 107
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Heparin Sodium Active Pharmaceutical Ingredient will have significant change from previous year. By the most conservative estimates of global Heparin Sodium Active Pharmaceutical Ingredient market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Heparin Sodium Active Pharmaceutical Ingredient market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Heparin Sodium Active Pharmaceutical Ingredient market by product type, application, key manufacturers and key regions and countries. Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7. Heparin Sodium Heparin Calcium Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8. Low Molecular Heparin Preparation Standard Heparin Preparation This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3. Hepalink King-friend Biochemical Pharmaceutical Bioibérica Dongcheng Biochemicals Changshan Pharm Pfizer Jiulong Biochemicals Qianhong Bio-pharma Tiandong Opocrin Yino Pharma Limited Xinbai Deebio
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heparin Sodium Active Pharmaceutical Ingredient Consumption 2016-2026
2.1.2 Heparin Sodium Active Pharmaceutical Ingredient Consumption CAGR by Region
2.2 Heparin Sodium Active Pharmaceutical Ingredient Segment by Type
2.2.1 Heparin Sodium
2.2.2 Heparin Calcium
2.3 Heparin Sodium Active Pharmaceutical Ingredient Sales by Type
2.3.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021)
2.3.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue and Market Share by Type (2016-2021)
2.3.3 Global Heparin Sodium Active Pharmaceutical Ingredient Sale Price by Type (2016-2021)
2.4 Heparin Sodium Active Pharmaceutical Ingredient Segment by Application
2.4.1 Low Molecular Heparin Preparation
2.4.2 Standard Heparin Preparation
2.5 Heparin Sodium Active Pharmaceutical Ingredient Sales by Application
2.5.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sale Market Share by Application (2016-2021)
2.5.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue and Market Share by Application (2016-2021)
2.5.3 Global Heparin Sodium Active Pharmaceutical Ingredient Sale Price by Application (2016-2021)
3 Global Heparin Sodium Active Pharmaceutical Ingredient by Company
3.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Company
3.1.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Company (2019-2021)
3.1.2 Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Company (2019-2021)
3.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Company
3.2.1 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Company (2019-2021)
3.2.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Company (2019-2021)
3.3 Global Heparin Sodium Active Pharmaceutical Ingredient Sale Price by Company
3.4 Global Manufacturers Heparin Sodium Active Pharmaceutical Ingredient Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heparin Sodium Active Pharmaceutical Ingredient Product Location Distribution
3.4.2 Players Heparin Sodium Active Pharmaceutical Ingredient Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Heparin Sodium Active Pharmaceutical Ingredient by Region
4.1 Global Heparin Sodium Active Pharmaceutical Ingredient by Region
4.1.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Region
4.1.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region
4.2 Americas Heparin Sodium Active Pharmaceutical Ingredient Sales Growth
4.3 APAC Heparin Sodium Active Pharmaceutical Ingredient Sales Growth
4.4 Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Growth
4.5 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Growth
5 Americas
5.1 Americas Heparin Sodium Active Pharmaceutical Ingredient Sales by Country
5.1.1 Americas Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021)
5.1.2 Americas Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021)
5.2 Americas Heparin Sodium Active Pharmaceutical Ingredient Sales by Type
5.3 Americas Heparin Sodium Active Pharmaceutical Ingredient Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heparin Sodium Active Pharmaceutical Ingredient Sales by Region
6.1.1 APAC Heparin Sodium Active Pharmaceutical Ingredient Sales by Region (2016-2021)
6.1.2 APAC Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2016-2021)
6.2 APAC Heparin Sodium Active Pharmaceutical Ingredient Sales by Type
6.3 APAC Heparin Sodium Active Pharmaceutical Ingredient Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Heparin Sodium Active Pharmaceutical Ingredient by Country
7.1.1 Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021)
7.1.2 Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021)
7.2 Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Type
7.3 Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient by Country
8.1.1 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021)
8.1.2 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021)
8.2 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Type
8.3 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Heparin Sodium Active Pharmaceutical Ingredient Distributors
10.3 Heparin Sodium Active Pharmaceutical Ingredient Customer
11 Global Heparin Sodium Active Pharmaceutical Ingredient Market Forecast
11.1 Global Heparin Sodium Active Pharmaceutical Ingredient Forecast by Region
11.1.1 Global Heparin Sodium Active Pharmaceutical Ingredient Forecast by Regions (2021-2026)
11.2.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Heparin Sodium Active Pharmaceutical Ingredient Forecast by Type
11.7 Global Heparin Sodium Active Pharmaceutical Ingredient Forecast by Application
12 Key Players Analysis
12.1 Hepalink
12.1.1 Hepalink Company Information
12.1.2 Hepalink Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.1.3 Hepalink Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Hepalink Main Business Overview
12.1.5 Hepalink Latest Developments
12.2 King-friend Biochemical Pharmaceutical
12.2.1 King-friend Biochemical Pharmaceutical Company Information
12.2.2 King-friend Biochemical Pharmaceutical Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.2.3 King-friend Biochemical Pharmaceutical Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 King-friend Biochemical Pharmaceutical Main Business Overview
12.2.5 King-friend Biochemical Pharmaceutical Latest Developments
12.3 Bioibérica
12.3.1 Bioibérica Company Information
12.3.2 Bioibérica Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.3.3 Bioibérica Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Bioibérica Main Business Overview
12.3.5 Bioibérica Latest Developments
12.4 Dongcheng Biochemicals
12.4.1 Dongcheng Biochemicals Company Information
12.4.2 Dongcheng Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.4.3 Dongcheng Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Dongcheng Biochemicals Main Business Overview
12.4.5 Dongcheng Biochemicals Latest Developments
12.5 Changshan Pharm
12.5.1 Changshan Pharm Company Information
12.5.2 Changshan Pharm Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.5.3 Changshan Pharm Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Changshan Pharm Main Business Overview
12.5.5 Changshan Pharm Latest Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.6.3 Pfizer Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Pfizer Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Jiulong Biochemicals
12.7.1 Jiulong Biochemicals Company Information
12.7.2 Jiulong Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.7.3 Jiulong Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Jiulong Biochemicals Main Business Overview
12.7.5 Jiulong Biochemicals Latest Developments
12.8 Qianhong Bio-pharma
12.8.1 Qianhong Bio-pharma Company Information
12.8.2 Qianhong Bio-pharma Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.8.3 Qianhong Bio-pharma Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Qianhong Bio-pharma Main Business Overview
12.8.5 Qianhong Bio-pharma Latest Developments
12.9 Tiandong
12.9.1 Tiandong Company Information
12.9.2 Tiandong Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.9.3 Tiandong Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Tiandong Main Business Overview
12.9.5 Tiandong Latest Developments
12.10 Opocrin
12.10.1 Opocrin Company Information
12.10.2 Opocrin Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.10.3 Opocrin Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Opocrin Main Business Overview
12.10.5 Opocrin Latest Developments
12.11 Yino Pharma Limited
12.11.1 Yino Pharma Limited Company Information
12.11.2 Yino Pharma Limited Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.11.3 Yino Pharma Limited Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Yino Pharma Limited Main Business Overview
12.11.5 Yino Pharma Limited Latest Developments
12.12 Xinbai
12.12.1 Xinbai Company Information
12.12.2 Xinbai Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.12.3 Xinbai Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Xinbai Main Business Overview
12.12.5 Xinbai Latest Developments
12.13 Deebio
12.13.1 Deebio Company Information
12.13.2 Deebio Heparin Sodium Active Pharmaceutical Ingredient Product Offered
12.13.3 Deebio Heparin Sodium Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Deebio Main Business Overview
12.13.5 Deebio Latest Developments
13 Research Findings and Conclusion
List of Tables Table 1. Heparin Sodium Active Pharmaceutical Ingredient Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Heparin Sodium Table 3. Major Players of Heparin Calcium Table 4. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021) & (Billion Units) Table 5. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) Table 6. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Type (2016-2021) & ($ million) Table 7. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021) Table 8. Global Heparin Sodium Active Pharmaceutical Ingredient Sale Price by Type (2016-2021) Table 9. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021) & (Billion Units) Table 10. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) Table 11. Global Heparin Sodium Active Pharmaceutical Ingredient Value by Application (2016-2021) Table 12. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Application (2016-2021) Table 13. Global Heparin Sodium Active Pharmaceutical Ingredient Sale Price by Application (2016-2021) Table 14. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Company (2019-2021) & (Billion Units) Table 15. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Company (2019-2021) Table 16. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Company (2019-2021) ($ Millions) Table 17. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Company (2019-2021) Table 18. Global Heparin Sodium Active Pharmaceutical Ingredient Sale Price by Company (2019-2021) Table 19. Key Manufacturers Heparin Sodium Active Pharmaceutical Ingredient Producing Area Distribution and Sales Area Table 20. Players Heparin Sodium Active Pharmaceutical Ingredient Products Offered Table 21. Heparin Sodium Active Pharmaceutical Ingredient Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Region (2016-2021) (Billion Units) Table 25. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2021) Table 26. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Region (2016-2021) Table 28. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (Billion Units) Table 29. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 30. Americas Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 32. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021) & (Billion Units) Table 33. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) Table 34. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021) & (Billion Units) Table 35. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) Table 36. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales by Region (2016-2021) & (Billion Units) Table 37. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2021) Table 38. APAC Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Region (2016-2021) Table 40. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021) & (Billion Units) Table 41. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) Table 42. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021) & (Billion Units) Table 43. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) Table 44. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (Billion Units) Table 45. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 46. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 48. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021) & (Billion Units) Table 49. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) Table 50. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021) & (Billion Units) Table 51. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (Billion Units) Table 53. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021) & (Billion Units) Table 57. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021) & (Billion Units) Table 59. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Heparin Sodium Active Pharmaceutical Ingredient Table 61. Key Application and Potential Industries of Heparin Sodium Active Pharmaceutical Ingredient Table 62. Key Challenges of Heparin Sodium Active Pharmaceutical Ingredient Table 63. Key Trends of Heparin Sodium Active Pharmaceutical Ingredient Table 64. Heparin Sodium Active Pharmaceutical Ingredient Distributors List Table 65. Heparin Sodium Active Pharmaceutical Ingredient Customer List Table 66. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) & (Billion Units) Table 67. Global Heparin Sodium Active Pharmaceutical Ingredient Consumption Market Forecast by Region Table 68. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) & (Billion Units) Table 71. Americas Heparin Sodium Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) & (Billion Units) Table 73. APAC Heparin Sodium Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) & (Billion Units) Table 75. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) & (Billion Units) Table 77. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026) & (Billion Units) Table 79. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share Forecast by Type (2021-2026) Table 80. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026) & (Billion Units) Table 83. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2021-2026) Table 84. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share Forecast by Application (2021-2026) Table 86. Hepalink Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 87. Hepalink Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 88. Hepalink Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 89. Hepalink Main Business Table 90. Hepalink Latest Developments Table 91. King-friend Biochemical Pharmaceutical Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 92. King-friend Biochemical Pharmaceutical Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 93. King-friend Biochemical Pharmaceutical Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 94. King-friend Biochemical Pharmaceutical Main Business Table 95. King-friend Biochemical Pharmaceutical Latest Developments Table 96. Bioibérica Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 97. Bioibérica Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 98. Bioibérica Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 99. Bioibérica Main Business Table 100. Bioibérica Latest Developments Table 101. Dongcheng Biochemicals Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 102. Dongcheng Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 103. Dongcheng Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 104. Dongcheng Biochemicals Main Business Table 105. Dongcheng Biochemicals Latest Developments Table 106. Changshan Pharm Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 107. Changshan Pharm Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 108. Changshan Pharm Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 109. Changshan Pharm Main Business Table 110. Changshan Pharm Latest Developments Table 111. Pfizer Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 112. Pfizer Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 113. Pfizer Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 114. Pfizer Main Business Table 115. Pfizer Latest Developments Table 116. Jiulong Biochemicals Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 117. Jiulong Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 118. Jiulong Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 119. Jiulong Biochemicals Main Business Table 120. Jiulong Biochemicals Latest Developments Table 121. Qianhong Bio-pharma Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 122. Qianhong Bio-pharma Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 123. Qianhong Bio-pharma Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 124. Qianhong Bio-pharma Main Business Table 125. Qianhong Bio-pharma Latest Developments Table 126. Tiandong Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 127. Tiandong Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 128. Tiandong Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 129. Tiandong Main Business Table 130. Tiandong Latest Developments Table 131. Opocrin Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 132. Opocrin Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 133. Opocrin Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 134. Opocrin Main Business Table 135. Opocrin Latest Developments Table 136. Yino Pharma Limited Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 137. Yino Pharma Limited Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 138. Yino Pharma Limited Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 139. Yino Pharma Limited Main Business Table 140. Yino Pharma Limited Latest Developments Table 141. Xinbai Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 142. Xinbai Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 143. Xinbai Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 144. Xinbai Main Business Table 145. Xinbai Latest Developments Table 146. Deebio Basic Information, Heparin Sodium Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors Table 147. Deebio Heparin Sodium Active Pharmaceutical Ingredient Product Offered Table 148. Deebio Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Revenue ($ Million), Price (US$/Billion Untis) and Gross Margin (2019-2021E) Table 149. Deebio Main Business Table 150. Deebio Latest Developments List of Figures Figure 1. Picture of Heparin Sodium Active Pharmaceutical Ingredient Figure 2. Heparin Sodium Active Pharmaceutical Ingredient Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Growth Rate 2016-2026 (Billion Units) Figure 7. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Heparin Sodium Active Pharmaceutical Ingredient Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Heparin Sodium Figure 10. Product Picture of Heparin Calcium Figure 11. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 Figure 12. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021) Figure 13. Heparin Sodium Active Pharmaceutical Ingredient Consumed in Low Molecular Heparin Preparation Figure 14. Global Heparin Sodium Active Pharmaceutical Ingredient Market: Low Molecular Heparin Preparation (2016-2021) & (Billion Units) Figure 15. Heparin Sodium Active Pharmaceutical Ingredient Consumed in Standard Heparin Preparation Figure 16. Global Heparin Sodium Active Pharmaceutical Ingredient Market: Standard Heparin Preparation (2016-2021) & (Billion Units) Figure 17. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) Figure 18. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Application in 2020 Figure 19. Heparin Sodium Active Pharmaceutical Ingredient Revenue Market by Company in 2020 ($ Million) Figure 20. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Company in 2020 Figure 21. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Regions (2016-2021) Figure 22. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Region in 2020 Figure 23. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales 2016-2021 (Billion Units) Figure 24. Americas Heparin Sodium Active Pharmaceutical Ingredient Revenue 2016-2021 ($ Millions) Figure 25. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales 2016-2021 (Billion Units) Figure 26. APAC Heparin Sodium Active Pharmaceutical Ingredient Revenue 2016-2021 ($ Millions) Figure 27. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales 2016-2021 (Billion Units) Figure 28. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales 2016-2021 (Billion Units) Figure 30. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue 2016-2021 ($ Millions) Figure 31. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country in 2020 Figure 32. Americas Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country in 2020 Figure 33. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 Figure 34. Americas Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 Figure 35. United States Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Region in 2020 Figure 40. APAC Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Regions in 2020 Figure 41. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 Figure 42. APAC Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 Figure 43. China Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 47. India Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country in 2020 Figure 50. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country in 2020 Figure 51. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 Figure 52. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 Figure 53. Germany Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 54. France Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 Figure 62. Egypt Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Heparin Sodium Active Pharmaceutical Ingredient Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles
Hepalink King-friend Biochemical Pharmaceutical Bioibérica Dongcheng Biochemicals Changshan Pharm Pfizer Jiulong Biochemicals Qianhong Bio-pharma Tiandong Opocrin Yino Pharma Limited Xinbai Deebio
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
According to our LPI (LP Information) latest study, the global Heparin Sodium Active Pharmaceutical Ingredient market size was valued at US$ 2577.8 million in 2023. With growing demand in downstream market, the Heparin Sodium Active Pharmaceutical Ingredient is forecast to a readjusted size of US$ 6052.2 million by 2030 with a CAGR of 13.0% during review period.
$3660.00